Literature DB >> 17208387

Active breathing control for Hodgkin's disease in childhood and adolescence: feasibility, advantages, and limits.

Line Claude1, Claude Malet, Pascal Pommier, Philippe Thiesse, Sylvie Chabaud, Christian Carrie.   

Abstract

PURPOSE: The challenge in early Hodgkin's disease (HD) in children is to maintain good survival rates while sparing organs at risk. This study assesses the feasibility of active breathing control (ABC) in children, and compares normal tissue irradiation with and without ABC. METHODS AND MATERIALS: Between May 2003 and June 2004, seven children with HD with mediastinal involvement, median age 15, were treated by chemotherapy and involved-field radiation therapy. A free-breathing computed tomography simulation scan and one additional scan during deep inspiration using ABC were performed. A comparison between planning treatment with clinical target volume including supraclavicular regions, mediastinum, and hila was performed, both in free breathing and using ABC.
RESULTS: For a prescription of 36 Gy, pulmonary dose-volume histograms revealed a mean reduction in lung volume irradiated at more than 20 Gy (V20) and 30 Gy (V30) of 25% and 26%, respectively, using ABC (p = 0.016). The mean volume of heart irradiated at 30 Gy or more decreased from 15% to 12% (nonsignificant). The mean dose delivered to breasts in girls was small in both situations (less than 2 Gy) and stable with or without ABC. Considering axillary irradiation, the mean dose delivered to breasts remained low (<9 Gy), without significant difference using ABC or not. The mean radiation dose delivered to thyroid was stable using ABC or not.
CONCLUSIONS: Using ABC is feasible in childhood. The use of ABC decreases normal lung tissue irradiation. Concerning heart irradiation, a minimal gain is also shown. No significant change has been demonstrated concerning breast and thyroid irradiation.

Entities:  

Mesh:

Year:  2007        PMID: 17208387     DOI: 10.1016/j.ijrobp.2006.11.008

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

2.  TEDDI: radiotherapy delivery in deep inspiration for pediatric patients - a NOPHO feasibility study.

Authors:  Anni Young Lundgaard; Lisa Lyngsie Hjalgrim; Laura Ann Rechner; Mirjana Josipovic; Morten Joergensen; Marianne Camille Aznar; Anne Kill Berthelsen; Lise Borgwardt; Christoffer Johansen; Annika Loft; Akmal Safwat; Leila Vaalavirta; Lena Specht; Maja Vestmoe Maraldo
Journal:  Radiat Oncol       Date:  2018-03-27       Impact factor: 3.481

3.  Predictive value of pediatric respiratory-induced diaphragm motion quantified using pre-treatment 4DCT and CBCTs.

Authors:  Sophie C Huijskens; Irma W E M van Dijk; Jorrit Visser; Brian V Balgobind; Coen R N Rasch; Tanja Alderliesten; Arjan Bel
Journal:  Radiat Oncol       Date:  2018-10-11       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.